论文部分内容阅读
目的观察在常规降压治疗基础上加用灯盏细辛注射液治疗原发性高血压的疗效。方法将180例1~2级高血压病随机分为治疗组和对照组各90例,对照组仅用西药常规降压治疗,治疗组在常规治疗基础上加用灯盏细辛注射液治疗。结果治疗组降血压疗效与对照组相近,但舒张压的降低较对照组更明显(P<0.05);治疗组临床症状改善及临床综合疗效明显优于对照组(P<0.05)。治疗组高切黏度、低切黏度、血浆黏度、红细胞聚集指数明显低于对照组(P<0.05)。结论在常规降压治疗基础上加用灯盏细辛注射液治疗高血压病能提高临床疗效,改善血黏度。
Objective To observe the curative effect of adding Erigeron Breviscapus Injection on essential hypertension based on conventional antihypertensive treatment. Methods 180 cases of grade 1 ~ 2 hypertension were randomly divided into treatment group and control group of 90 cases, the control group only conventional antihypertensive treatment, the treatment group on the basis of conventional treatment with Erigeron Breviscapus injection. Results The therapeutic effect of lowering blood pressure in the treatment group was similar to that in the control group, but the decrease of diastolic pressure was more obvious than that in the control group (P <0.05). The improvement of clinical symptoms and clinical efficacy in the treatment group were significantly better than those in the control group (P <0.05). The high shear viscosity, low shear viscosity, plasma viscosity and erythrocyte aggregation index in the treatment group were significantly lower than those in the control group (P <0.05). Conclusion Based on the conventional antihypertensive treatment, adding Erigeron Breviscapus Injection to the treatment of hypertension can improve the clinical curative effect and improve the blood viscosity.